Cannabinoid hyperemesis syndrome (CHS), a recurring vomiting disorder triggered by long-term, frequent cannabis use, remains underdiagnosed and often leads to unnecessary diagnostic evaluations, increased health care utilization, and mental health burden. We present a large case series of CHS in pediatrics that includes data on treatment efficacy, health care utilization, and comorbidities.
Castellvi et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: